Pathological biopsy strategy by regulating intracellular ROS to precisely differentiate cancer cells from diseased tissues.
Chem Commun (Camb)
; 60(56): 7172-7175, 2024 Jul 09.
Article
in En
| MEDLINE
| ID: mdl-38904347
ABSTRACT
We have developed an innovative pathological biopsy strategy by expanding the differences of ROS levels among cancer cells, inflammatory cells and normal cells using cross-linked lipoic acid vesicles loaded with vitamin C (VC@cLAVs), combined with chemiluminescence imaging technology. By analyzing the different trends of intracellular chemiluminescence intensity, the three types of cells were quickly and accurately differentiated from diseased tissues, thus holding clinical tumor diagnostic potential.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ascorbic Acid
/
Thioctic Acid
/
Reactive Oxygen Species
Limits:
Humans
Language:
En
Journal:
Chem Commun (Camb)
Journal subject:
QUIMICA
Year:
2024
Document type:
Article
Affiliation country: